Bank of Montreal
TXG icon

Bank of Montreal’s 10x Genomics TXG Stock Holding History

Bank of Montreal’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$558K Sell
26,302
-4,415
-14% -$88.3K ﹤0.01% 2340
2025
Q4 		$501K Sell
30,717
-557,894
-95% -$8.43M ﹤0.01% 2311
2025
Q3 		$6.88M Buy
588,611
+531
+0.1% +$6.92K ﹤0.01% 1185
2025
Q2 		$6.81M Buy
588,080
+576,047
+4,787% +$5.25M ﹤0.01% 1136
2025
Q1 		$105K Buy
+12,033
New +$152K ﹤0.01% 2908
2024
Q4 		– Sell
-14,576
Closed -$330K – 3943
2024
Q3 		$330K Buy
+14,576
New +$301K ﹤0.01% 2706
2024
Q2 		– Sell
-5,628
Closed -$262K – 4256
2024
Q1 		$262K Sell
5,628
-399,717
-99% -$17.6M ﹤0.01% 2870
2023
Q4 		$23.4M Buy
405,345
+398,760
+6,056% +$17.4M 0.01% 734
2023
Q3 		$328K Sell
6,585
-214,666
-97% -$11.2M ﹤0.01% 2742
2023
Q2 		$12.9M Buy
221,251
+214,425
+3,141% +$11.6M ﹤0.01% 917
2023
Q1 		$382K Sell
6,826
-15,097
-69% -$705K ﹤0.01% 2620
2022
Q4 		$802K Sell
21,923
-470
-2% -$15.4K ﹤0.01% 2324
2022
Q3 		$804 Buy
22,393
+17,470
+355% +$666K ﹤0.01% 2308
2022
Q2 		$242 Buy
4,923
+1,033
+27% +$53.6K ﹤0.01% 3153
2022
Q1 		$293K Sell
3,890
-29,747
-88% -$2.6M ﹤0.01% 3209
2021
Q4 		$5.08M Sell
33,637
-5,796
-15% -$888K ﹤0.01% 1217
2021
Q3 		$5.78M Buy
39,433
+1,594
+4% +$274K ﹤0.01% 1562
2021
Q2 		$7.63M Buy
37,839
+889
+2% +$161K ﹤0.01% 1399
2021
Q1 		$7.03M Buy
36,950
+35,960
+3,632% +$6.21M ﹤0.01% 1188
2020
Q4 		$166K Sell
990
-9,195
-90% -$1.33M ﹤0.01% 3330
2020
Q3 		$1.39M Buy
10,185
+10,123
+16,327% +$1.06M ﹤0.01% 1820
2020
Q2 		$6K Buy
62
+22
+55% +$1.71K ﹤0.01% 4387
2020
Q1 		$2K Hold
40
– – ﹤0.01% 3889
2019
Q4 		$3K Buy
+40
New +$2.4K ﹤0.01% 4757

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's TXG Position: Q1 2026 in Review

Bank of Montreal reduced its 10x Genomics (TXG) stake by 14% in Q1 2026, selling an estimated $88.3K and leaving 26,302 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #2340.

Bank of Montreal first reported a position in TXG in Q4 2019 and has held it in 24 quarters since. The position peaked at $23.4M in Q4 2023. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Bank of Montreal held 26,302 shares of 10x Genomics worth $558K as of Q1 2026.
  • Bank of Montreal sold 4,415 10x Genomics shares in Q1 2026, an estimated $88.3K.
  • 10x Genomics made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2340 holding.
  • Bank of Montreal first reported a position in 10x Genomics in Q4 2019 and has held it in 24 quarters since.
  • Bank of Montreal's 10x Genomics position peaked at $23.4M in Q4 2023.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.